Ex vivo human pancreatic cancer avatars; an in-line personalised therapeutic response assessment platform
A paradigm shift in long-term survival rates for patients with Pancreatic Ductal Adenocarcinoma (PDAC) has yet to be witnessed. Long-term survival is only achieved in a small minority of patients. Systemic control of the disease can be secured with chemotherapy, however PDAC harbours high rates of...
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Thesis |
| Language: | English |
| Published: |
2022
|
| Subjects: |